Results 61 to 70 of about 1,806,820 (366)

Coronary Artery Calcification [PDF]

open access: yesGlobal Heart, 2016
Coronary artery calcification (CAC) is an established marker of subclinical atherosclerosis and an independent predictor of future coronary heart disease in the asymptomatic primary prevention population, particularly in the intermediate risk cohort. CAC also helps in reclassifying those patients and their risk of cardiovascular events into higher or ...
Osawa, Kazuhiro   +2 more
openaire   +4 more sources

Current status of liver transplantation for non‐B non‐C liver cirrhosis and hepatocellular carcinoma

open access: yesAnnals of Gastroenterological Surgery, Volume 7, Issue 1, Page 42-52, January 2023., 2023
Recently, the cases of LT for non‐B non‐C cirrhosis and HCC have been increasing in Japan as well as worldwide. Perioperative management of non‐B non‐C liver disease is problematic due to various risk factors, including alcohol consumption and metabolic syndrome‐related risks, such as obesity and diabetes mellitus.
Takahiro Nishio   +4 more
wiley   +1 more source

Detecting human coronary inflammation by imaging perivascular fat

open access: yesScience Translational Medicine, 2017
Adipocyte size and lipid content in perivascular adipose tissue are inversely associated with coronary inflammation and atherosclerotic plaque burden in human patients.
A. Antonopoulos   +25 more
semanticscholar   +1 more source

Prediction of need for bowel resection in acute superior mesenteric artery occlusion: A retrospective study of 48 Japanese patients

open access: yesAnnals of Gastroenterological Surgery, Volume 7, Issue 1, Page 175-181, January 2023., 2023
In a study of 48 patients with acute superior mesenteric artery occlusion, a logistic regression model using time from onset to diagnosis and the occlusion site of superior mesenteric artery showed 78.6% sensitivity in ruling out cases requiring bowel resection.
Susumu Watada   +9 more
wiley   +1 more source

OPERATIONS FOR CORONARY ARTERY DISEASE

open access: yesArchives of Surgery, 1951
The primary problem of coronary artery disease concerns red blood to the heart muscle. Operative procedures can accomplish this objective. Two operations have been developed for this purpose. One consists of making intercoronary channels by producing an inflammatory reaction on the surface of the heart.
Richard S. Hahn   +3 more
openaire   +18 more sources

Aneurysmal coronary artery disease of the right coronary artery [PDF]

open access: yesEuropean Journal of Cardio-Thoracic Surgery, 2003
Coronary artery aneurysms are uncommon, with male dominance and uncertain natural history. The RCA is predilected in 50% of cases. Complications are thrombus, risk of rupture and vasospasm. Treatment is not clearly defined, only anecdotal experience exists. We treated two elder male patients with isolated large aneurysm of the RCA (Fig. 1a,b) presented
Jan Gummert   +3 more
openaire   +3 more sources

Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade

open access: yesCirculation, 2017
The Cardiovascular Disease in Women Committee of the American College of Cardiology, in conjunction with interested parties (from the National Heart, Lung, and Blood Institute, American Heart Association, and European Society of Cardiology), convened a ...
N. Merz, C. Pepine, M. Walsh, J. Fleg
semanticscholar   +1 more source

Identifying, characterizing, and classifying congenital anomalies of the coronary arteries.

open access: yesRadiographics, 2012
The clinical manifestations of coronary artery anomalies vary in severity, with some anomalies causing severe symptoms and cardiovascular sequelae and others being benign.
J. Shriki   +9 more
semanticscholar   +1 more source

Bruton tyrosine kinase inhibitors in the management of Waldenström macroglobulinemia

open access: yesAmerican Journal of Hematology, Volume 98, Issue 2, Page 338-347, February 2023., 2023
Abstract Bruton tyrosine kinase (BTK) inhibitors have taken a central role in the management of patients with Waldenström macroglobulinemia and are the only agents approved by the Food and Drug Administration (FDA) to treat these patients. Although associated with high rates of durable responses, unmet needs with BTK inhibitor therapy include ...
Jorge J. Castillo   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy